ArticleBMJ open2022

Reduction effect of oral pravastatin on the acute phase response to intravenous zoledronic acid: protocol for a real-world prospective, placebo-controlled trial.

Qi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.